1. Home
  2. COR
  3. COR News

Latest Cencora Inc. (COR) News on November 4, 2025

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
COR

Zacks

4 days ago

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
COR

Zacks

4 days ago

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health
COR

StockStory

4 days ago

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health

Cencora (COR) Stock Is Up, What You Need To Know
COR

StockStory

5 days ago

Cencora (COR) Stock Is Up, What You Need To Know

COR

Morningstar Research

5 days ago

Analyst Report: Cardinal Health, Inc.

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
COR

Zacks

5 days ago

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Cencora (COR) Earnings Expected to Grow: Should You Buy?
COR

Zacks

6 days ago

Cencora (COR) Earnings Expected to Grow: Should You Buy?

Why Cencora (COR) is a Top Growth Stock for the Long-Term
COR

Zacks

6 days ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
COR

Zacks

7 days ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?
COR

Zacks

7 days ago

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs
COR

GlobeNewswire

7 days ago

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs

COR

MT Newswires

8 days ago

UBS Adjusts Cencora Price Target to $380 From $350, Maintains Buy Rating

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor
COR

PR Newswire

8 days ago

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month
COR

Simply Wall St.

9 days ago

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
COR

Zacks

11 days ago

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

Universal Health to Report Q3 Earnings: Key Estimates to Note
COR

Zacks

13 days ago

Universal Health to Report Q3 Earnings: Key Estimates to Note

What to Expect From Cencora's Q4 2025 Earnings Report
COR

Barchart

13 days ago

What to Expect From Cencora's Q4 2025 Earnings Report

COR

MT Newswires

14 days ago

Cencora Insider Sold Shares Worth $1,665,700, According to a Recent SEC Filing

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
COR

Zacks

14 days ago

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory
COR

Simply Wall St.

16 days ago

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory

COR

Business Wire

19 days ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US
COR

Business Wire

19 days ago

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

COR

MT Newswires

19 days ago

Mizuho Adjusts Price Target on Cencora to $334 From $316, Maintains Outperform Rating

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.
COR

Barrons.com

21 days ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

3 Market-Beating Stocks Worth Your Attention
COR

StockStory

21 days ago

3 Market-Beating Stocks Worth Your Attention

3 Reasons COR Has Explosive Upside Potential
COR

StockStory

21 days ago

3 Reasons COR Has Explosive Upside Potential

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?
COR

Simply Wall St.

22 days ago

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?

Here's Why Cencora (COR) is a Strong Growth Stock
COR

Zacks

22 days ago

Here's Why Cencora (COR) is a Strong Growth Stock

Bitcoin Miner Leads Two Health Care Stocks To New Highs
COR

Investor's Business Daily

25 days ago

Bitcoin Miner Leads Two Health Care Stocks To New Highs

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
COR

Zacks

25 days ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
COR

Zacks

a month ago

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

COR

Business Wire

a month ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

COR

MT Newswires

a month ago

Leerink Partners Adjusts Cencora Price Target to $361 From $349, Maintains Outperform Rating

COR

Morningstar Research

a month ago

Analyst Report: Cencora, Inc.

COR

Morningstar Research

a month ago

Analyst Report: McKesson Corporation

Cardinal Health Stock Scores Relative Strength Rating Upgrade
COR

Investor's Business Daily

a month ago

Cardinal Health Stock Scores Relative Strength Rating Upgrade

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
COR

StockStory

a month ago

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors
COR

Simply Wall St.

a month ago

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors

Why Cencora (COR) is a Top Growth Stock for the Long-Term
COR

Zacks

a month ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

1 Surging Stock with Exciting Potential and 2 We Find Risky
COR

StockStory

a month ago

1 Surging Stock with Exciting Potential and 2 We Find Risky

COR

Morningstar Research

a month ago

Analyst Report: McKesson Corporation

COR

Business Wire

a month ago

Kroll Settlement Administration Announces that The Lash Group, LLC Has Reached a Settlement Regarding a Data Security Incident

Top Analyst Reports for Apple, Eli Lilly & Chevron
COR

Zacks

a month ago

Top Analyst Reports for Apple, Eli Lilly & Chevron

Why Cencora (COR) Stock Is Trading Up Today
COR

StockStory

a month ago

Why Cencora (COR) Stock Is Trading Up Today

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025
COR

GlobeNewswire

a month ago

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025

COR

MT Newswires

a month ago

Cencora Insider Sold Shares Worth $1,478,130, According to a Recent SEC Filing

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
COR

Zacks

a month ago

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

COR

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $9,087,142, According to a Recent SEC Filing

COR

MT Newswires

2 months ago

Deutsche Bank Adjusts Price Target on Cencora to $322 From $328

COR

MT Newswires

2 months ago

Deutsche Bank Trims Price Target on Cencora to $322 From $328, Keeps Buy Rating

Cencora Stock: Is COR Outperforming the Health Care Sector?
COR

Barchart

2 months ago

Cencora Stock: Is COR Outperforming the Health Care Sector?

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?
COR

Zacks

2 months ago

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?

COR

MT Newswires

2 months ago

Argus Adjusts Price Target on Cencora to $340 From $330

COR

Argus Research

2 months ago

Analyst Report: Cencora Inc

COR

Argus Research

2 months ago

Market Digest: AAPL, COR, CCL, DECK, ETD, ETN, ORCL

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
COR

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Here's Why You Should Hold Cencora Stock in Your Portfolio Now
COR

Zacks

2 months ago

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Here's Why Cencora (COR) is a Strong Value Stock
COR

Zacks

2 months ago

Here's Why Cencora (COR) is a Strong Value Stock

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board
COR

Simply Wall St.

2 months ago

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board

COR vs. MEDP: Which Stock Is the Better Value Option?
COR

Zacks

2 months ago

COR vs. MEDP: Which Stock Is the Better Value Option?

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
COR

Zacks

2 months ago

Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns

COR

MT Newswires

2 months ago

Cencora Appoints Mark Durcan as Chairman

COR

Business Wire

2 months ago

Cencora Appoints Mark Durcan as Chairman of Its Board of Directors

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why
COR

Zacks

2 months ago

Cencora (COR) is an Incredible Growth Stock: 3 Reasons Why

COR

Morningstar Research

2 months ago

Analyst Report: McKesson Corporation

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
COR

Zacks

2 months ago

Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick

COR

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $4,227,618, According to a Recent SEC Filing

Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?
COR

Zacks

2 months ago

Is Climb Bio, Inc. (CLYM) Outperforming Other Medical Stocks This Year?

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
COR

Zacks

3 months ago

Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio

COR

Argus Research

3 months ago

Weekly Stock List

Cencora directors agree to $111M settlement over alleged opioid mismanagement
COR

Healthcare Dive

3 months ago

Cencora directors agree to $111M settlement over alleged opioid mismanagement

Why Cencora (COR) is a Top Value Stock for the Long-Term
COR

Zacks

3 months ago

Why Cencora (COR) is a Top Value Stock for the Long-Term

Cencora's (NYSE:COR) Earnings Seem To Be Promising
COR

Simply Wall St.

3 months ago

Cencora's (NYSE:COR) Earnings Seem To Be Promising

Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest
COR

StockStory

3 months ago

Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest

Cencora Stock: Analyst Estimates & Ratings
COR

Barchart

3 months ago

Cencora Stock: Analyst Estimates & Ratings

COR

MT Newswires

3 months ago

Wells Fargo Adjusts Price Target on Cencora to $354 From $337, Maintains Overweight Rating

The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call
COR

StockStory

3 months ago

The 5 Most Interesting Analyst Questions From Cencora’s Q2 Earnings Call

COR

Morningstar Research

3 months ago

Analyst Report: Cardinal Health, Inc.

COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update
COR

StockStory

3 months ago

COR Q2 Deep Dive: Specialty Growth, International Headwinds, and Guidance Update

3 Reasons Growth Investors Will Love Cencora (COR)
COR

Zacks

3 months ago

3 Reasons Growth Investors Will Love Cencora (COR)

COR

MT Newswires

3 months ago

JPMorgan Adjusts Price Target on Cencora to $344 From $326, Maintains Overweight Rating

Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend
COR

Simply Wall St.

3 months ago

Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend

Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
COR

Zacks

3 months ago

Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?

COR

Morningstar Research

3 months ago

Analyst Report: Cardinal Health, Inc.

COR

MT Newswires

3 months ago

Jefferies Adjusts Cencora Price Target to $310 From $300, Maintains Hold Rating

ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up
COR

Zacks

3 months ago

ZBH Stock Gains On Q2 Earnings and Revenue Beat, '25 EPS View Up

STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View
COR

Zacks

3 months ago

STE Beats on Q1 Earnings and Revenues, Raises '26 Sales View

COR

Morningstar Research

3 months ago

Analyst Report: McKesson Corporation

Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend
COR

Simply Wall St.

3 months ago

Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend

COR

Morningstar Research

3 months ago

Analyst Report: Cencora, Inc.

Mckesson lifts annual profit forecast on robust demand for specialty drugs
COR

Reuters

3 months ago

Mckesson lifts annual profit forecast on robust demand for specialty drugs

Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook
COR

Benzinga

3 months ago

Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook

COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised
COR

Zacks

3 months ago

COR Q3 Earnings & Revenues Beat Estimates, '25 EPS View Raised

Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
COR

Zacks

3 months ago

Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise
COR

Zacks

3 months ago

DexCom Stock Falls Despite Q2 Earnings Beat & 2025 Sales View Raise

ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down
COR

Zacks

3 months ago

ALGN Stock Falls on Q2 Earnings and Revenue Miss, Margins Down

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
COR

Zacks

3 months ago

Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Charles River Q2 Earnings Preview: What's in Store for the Stock?
COR

Zacks

3 months ago

Charles River Q2 Earnings Preview: What's in Store for the Stock?

Elevance names former Cencora CEO to board
COR

Healthcare Dive

3 months ago

Elevance names former Cencora CEO to board

Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates
COR

Zacks

3 months ago

Teladoc (TDOC) Reports Q2 Loss, Beats Revenue Estimates

Share on Social Networks: